Why the study?
Lipoproteins co-isolated with extracellular vesicles were initially regarded as contaminants, but emerging evidence shows they interact, share cargo, influence each others functions, and have therapeutic and pharmacological implications.
Key points are not available for this paper at this time.
Design
Minireview
Answers are grounded in this paper and cite their sources.
May inform lipid-lowering strategies; leaves open vesicle-lipoprotein targeting pending interventional studies.
In recent years, various approaches have been undertaken to eliminate lipoproteins co-isolated with extracellular vesicles, as they were initially regarded as contaminating entities. However, novel discoveries are reshaping our perspective. In body fluids, these distinct particles not only co-exist, but also interactions between them are likely to occur. Extracellular vesicles and lipoproteins can associate with each other, share cargo, influence each other's functions, and jointly have a role in the pathomechanisms of diseases. Additionally, their association carries important implications for therapeutic and pharmacological aspects of lipid-lowering strategies. Extracellular vesicles and lipoprotein particles may have roles in the elimination of each other from the circulation. The objective of this minireview is to delve into these aspects. Here, we show that under certain physiological and pathological conditions, extracellular vesicles and lipoproteins are 'partners' rather than 'strangers' or 'rivals'.
No takes yet. Share an insight, caveat, or question.
Németh et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: